MGCD / MGC Diagnostics Corp. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

MGCD / MGC Diagnostics Corp. / PERCEPTIVE ADVISORS LLC - AMENDMENT NO. 3 TO SCHEDULE 13G Passive Investment

Amendment No. 3 to Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* MGC Diagnostics Corporation (Name of Issuer) Common Stock, $0.10 Par Value (Title of Class of Securities) 552768 10 3 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appro

MGCD / MGC Diagnostics Corp. / Radoff Bradley Louis - SC 13G/A Passive Investment

SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A (Amendment No.

MGCD / MGC Diagnostics Corp. FORM 15

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-13543 MGC Diagnostics Corporation (Exact name of registrant as specifie

MGCD / MGC Diagnostics Corp. / GAMCO INVESTORS, INC. ET AL Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) MGC Diagnostics Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 552768103 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorized t

MGCD / MGC Diagnostics Corp. S-8 POS

As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

MGCD / MGC Diagnostics Corp. S-8 POS

As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

MGCD / MGC Diagnostics Corp. S-8 POS

S-8 POS 1 mgc173448s8pos5387.htm S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No. 333-105387 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO Form S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MGC DIAGNOSTICS CORPORATION (Exact name of registrant as specified in its charter) Min

MGCD / MGC Diagnostics Corp. S-8 POS

S-8 POS 1 mgc173447s8pos2171.htm S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No. 333-102171 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO Form S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MGC DIAGNOSTICS CORPORATION (Exact name of registrant as specified in its charter) Min

MGCD / MGC Diagnostics Corp. S-8 POS

As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

MGCD / MGC Diagnostics Corp. S-8 POS

As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

MGCD / MGC Diagnostics Corp. S-8 POS

As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

MGCD / MGC Diagnostics Corp. S-8 POS

As filed with the Securities and Exchange Commission on December 29, 2017 Registration No.

MGCD / MGC Diagnostics Corp. S-8 POS

S-8 POS 1 mgc173452s8pos7102.htm S-8 POS As filed with the Securities and Exchange Commission on December 29, 2017 Registration No. 333-167102 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO Form S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MGC DIAGNOSTICS CORPORATION (Exact name of registrant as specified in its charter) Min

Second Amended and Restated Articles of Incorporation of MGC Diagnostics Corporation

Exhibit 3.1 SECOND AMENDED AND RESTATED ARTICLES OF INCORPORATION OF MGC DIAGNOSTICS CORPORATION Pursuant to the provisions of Chapter 302A of the Minnesota Statutes, known as the Minnesota Business Corporation Act, the following Second Amended and Restated Articles of Incorporation are adopted and shall supercede, amend and restate in their entirety the existing Amended and Restated Articles of I

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 28, 2017 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota 001-13543 41-1579150 (State or other jurisdiction of incorporation) (Com

Second Amended and Restated Bylaws of MGC Diagnostics Corporation

Exhibit 3.2 SECOND AMENDED AND RESTATED BYLAWS OF MGC DIAGNOSTICS CORPORATION (as of December 28, 2017) ARTICLE I Meetings of Shareholders Section 1.1. Annual Meetings. If required by applicable law, an annual meeting of shareholders shall be held for the election of directors at such date, time and place, if any, either within or without the State of Minnesota, as may be designated by resolution

MGCD / MGC Diagnostics Corp. SCHEDULE 14D-9/A

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (RULE 14d-101) (Amendment No. 2) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 MGC DIAGNOSTICS CORPORATION. (Name of Subject Company) MGC DIAGNOSTICS CORPORATION. (Name of Person(s) Filing Statement) Common Stock (Title of Class of Securities) 552768103 (CUSIP Number of Cl

MGCD / MGC Diagnostics Corp. / GAMCO INVESTORS, INC. ET AL Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 MGC Diagnostics Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 552768103 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorized to Receive Notices

MGCD / MGC Diagnostics Corp. SCHEDULE 14D-9/A

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (RULE 14d-101) (Amendment No. 1) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 MGC DIAGNOSTICS CORPORATION. (Name of Subject Company) MGC DIAGNOSTICS CORPORATION. (Name of Person(s) Filing Statement) Common Stock (Title of Class of Securities) 552768103 (CUSIP Number of Cl

MGCD / MGC Diagnostics Corp. SCHEDULE 14D-9

Lindquist 12/5/2017 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (RULE 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 MGC DIAGNOSTICS CORPORATION (Name of Subject Company) MGC DIAGNOSTICS CORPORATION (Name of Person(s) Filing Statement) Common Stock (Title of Class of Securities) 552768103 (CUSIP Number of Cl

December 6, 2017

EX-99.A2C 2 mgc173297ex99-a2c.htm LETTER TO THE SHAREHOLDERS FROM THE CHAIRMAN OF THE BOARD, DATED NOVEMBER 6, 2017 Exhibit (a)(2)(C) December 6, 2017 Dear MGC Diagnostics Corporation Shareholder: We are pleased to inform you that on November 25, 2017, MGC Diagnostics Corporation (“MGCD”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with MGC Parent LLC (“Parent”) and AC Br

MGCD / MGC Diagnostics Corp. FORM 8-K DATED NOVEMBER 25, 2017 (Current Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 25, 2017 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota 001-13543 41-1579150 (State or other jurisdiction of incorporation) (Com

Agreement and Plan of Merger, dated as of November 25, 2017, by and among MGC Parent LLC, a Delaware limited liability company, AC Breathe Merger Sub Inc., a Minnesota corporation and a wholly-owned subsidiary of Parent, and MGC Diagnostics Corporation, a Minnesota corporation.

Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER by and among MGC PARENT LLC, AC BREATHE MERGER SUB INC. and MGC DIAGNOSTICS CORPORATION dated as of November 25, 2017 TABLE OF CONTENTS ARTICLE I. THE OFFER 2 Section 1.01 The Offer 2 Section 1.02 Company Actions 6 Section 1.03 Directors 7 Section 1.04 Top-Up Option 8 ARTICLE II. THE MERGER 10 Section 2.01 The Merger 10 Section 2.02 Closin

Form of Tender Support Agreement between MGC Parent LLC, AC Breathe Merger Sub Inc., and MGC Diagnostics Corporation directors and officers.

Exhibit 10.1 FORM OF TENDER SUPPORT AGREEMENT A Tender Support Agreement in this form has been entered into WITH each Stockholder listed on Schedule A hereto. Schedule A to this form of agreement sets forth the share ownership of all of the Stockholders to such agreements; however, each Stockholder?s individual Tender Support Agreement lists only the share ownership of that Stockholder. This TENDE

MGC Diagnostics Corporation agrees to Be Acquired By Altus Capital partners

Exhibit 99.1 MGC Diagnostics Corporation agrees to Be Acquired By Altus Capital partners November 27, 2017. Saint Paul, Minnesota. MGC Diagnostics Corporation, (Nasdaq: MGCD) a global medical technology company (“MGCD”), announced it has agreed to be acquired by affiliates of Altus Capital Partners, Inc. (“Altus”). Altus is a private equity firm that makes control investments in middle market manu

MGC Diagnostics Corporation Employee Question & Answer Information Summary (November 27, 2017)

Exhibit 99.2 MGC Diagnostics Corporation Employee Question & Answer Information Summary (November 27, 2017) 1. Who is buying MGC Diagnostics Corporation (“MGCD”)? MGCD announced today it has agreed to be purchased by affiliates of Altus Capital Partners, Inc. (“Altus”). Altus is a private equity firm that makes control investments in middle market manufacturing businesses. 2. How will this happen?

MGCD / MGC Diagnostics Corp. SC 14D9C

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (RULE 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 MGC DIAGNOSTICS CORPORATION. (Name of Subject Company) MGC DIAGNOSTICS CORPORATION. (Name of Person(s) Filing Statement) Common Stock (Title of Class of Securities) 552768103 (CUSIP Number of Class of Securities)

Quarterly Report - FORM 10-Q FOR THE QUARTER ENDED JULY 31, 2017

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended July 31, 2017. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to . Commission File Number 001-13543 MGC DIAGNOSTICS COR

MGC Diagnostics Corporation Reports Fiscal 2017 Third Quarter Results Strong Quarterly Revenue up 6% and Net Income up 193%; International revenues increased 8.5%

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Reports Fiscal 2017 Third Quarter Results Strong Quarterly Revenue up 6% and Net Income up 193%; International revenues increased 8.5% SAINT PAUL, MN ? September 6, 2017 ? MGC Diagnostics Corporation (NASDAQ: MGCD)

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 6, 2017 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics FORM 8-K DATED AUGUST 30, 2017 (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 30, 2017 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

Quarterly Report - FORM 10-Q FOR THE QUARTER ENDED APRIL 30, 2017

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended April 30, 2017. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to . Commission File Number 001-13543 MGC DIAGNOSTICS CO

FIFTH ADDENDUM TO LEASE

Exhibit 10.1 FIFTH ADDENDUM TO LEASE This Fifth Addendum to Lease (the "Fifth Addendum") is made and entered into this 5th day of May, 2017, as an addendum to that certain Lease for the real property located at 350 Oak Grove Parkway, Vadnais Heights, Minnesota, made as of December 15, 2003, by and between VRT Properties, LLC, as successor to Vadnais Heights Investment Company, a Minnesota general

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 1, 2017 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics Corporation Reports Fiscal 2017 Second Quarter Results Strong Quarterly Revenue; Total international revenues increased 16%

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Reports Fiscal 2017 Second Quarter Results Strong Quarterly Revenue; Total international revenues increased 16% SAINT PAUL, MN ? June 1, 2017 ? MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technolog

MGC Diagnostics FORM SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form SD Specialized Disclosure Report MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota 001-13543 41-1579150 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics Corporation CONFLICT MINERALS REPORT Reporting Year: 2016

Exhibit 1.01 MGC Diagnostics Corporation CONFLICT MINERALS REPORT Reporting Year: 2016 This is the Conflict Minerals Report (“Report”) of MGC Diagnostics Corporation (“MGCD” or the “Company”) for the 2016 calendar year in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exchange Act of 1934 (“the 1934 Act”). Please refer to Rule 13p-1, Form SD and the 1934 Act Release No. 34-67716 (A

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 22, 2017 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics FORM 8-K DATED MARCH 16, 2017 (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 16, 2017 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

Quarterly Report - FORM 10-Q FOR THE QUARTER ENDED JANUARY 31, 2017

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended January 31, 2017. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to . Commission File Number 001-13543 MGC DIAGNOSTICS

MGC Diagnostics FORM 8-K DATED MARCH 7, 2017 (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 7, 2017 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics Corporation Reports Fiscal 2017 First Quarter Results Total international revenues increased 9%

MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Reports Fiscal 2017 First Quarter Results Total international revenues increased 9% SAINT PAUL, MN ? March 7, 2017 ? MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today reported financial results for the first quarter ended January 31, 2017.

MGCD / MGC Diagnostics Corp. / PERCEPTIVE ADVISORS LLC - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Amendment No. 2) Under the Securities Exchange Act of 1934 MGC Diagnostics Corp (Name of Issuer) Common Stock (Title of Class of Securities) 552768103 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this S

MGCD / MGC Diagnostics Corp. / PERCEPTIVE ADVISORS LLC - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Amendment No. 2) Under the Securities Exchange Act of 1934 MGC Diagnostics Corp (Name of Issuer) Common Stock (Title of Class of Securities) 552768103 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this S

MGCD / MGC Diagnostics Corp. / Radoff Bradley Louis - SC 13G/A Passive Investment

SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A (Amendment No.

MGC Diagnostics DEFINITIVE ADDITIONAL MATERIALS

SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

MGC Diagnostics DEFINITIVE PROXY STATEMENT

SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

Annual Report - FORM 10-K FOR THE FISCAL YEAR ENDED OCTOBER 31, 2016

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended October 31, 2016. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to . Commission File Number 001-13543 MGC DIAGNOSTICS CORPORAT

Subsidiaries of MGC Diagnostics Corporation

Exhibit 21 Subsidiaries of MGC Diagnostics Corporation Name of Subsidiary Jurisdiction of Incorporation or Organization Medical Graphics Corporation Minnesota MGC Diagnostics Belgium S.P.R.L. Belgium Medisoft SA Belgium

MGC Diagnostics FORM 8-K DATED JANUARY 25, 2017 (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 25, 2017 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics Corporation Reports Fiscal 2016 Fourth Quarter and Year End Results Fiscal year Competitive Account Wins increased 35% and Competitive Account Revenues increased 79%; Total domestic revenues increased 14%

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Reports Fiscal 2016 Fourth Quarter and Year End Results Fiscal year Competitive Account Wins increased 35% and Competitive Account Revenues increased 79%; Total domestic revenues increased 14% SAINT PAUL, MN – Janu

MGC Diagnostics Corporation Declares $0.70 Per Share Special Cash Dividend and Retains Investment Banking Firm to Explore Strategic Options

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Declares $0.70 Per Share Special Cash Dividend and Retains Investment Banking Firm to Explore Strategic Options SAINT PAUL, MN (January 25, 2017) ? MGC Diagnostics Corporation (NasdaqCM: MGCD), a global medical tec

MGC Diagnostics FORM 8-K DATED JANUARY 25, 2017 (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 25, 2017 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics FORM 10-Q FOR THE QUARTER ENDED JULY 31, 2016 (Quarterly Report)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended July 31, 2016. OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to . Commission File Number 001-13543 M

MGC Diagnostics FORM 8-K DATED SEPTEMBER 7, 2016 (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 7, 2016 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

Competitive Conversion Wins Competitive Conversion Revenue

Exhibit 99.1 SAINT PAUL, MN ? September 7, 2016 THIRD QUARTER 2016 REVENUE $9.9M EARNINGS PER DILUTED SHARE $0.06 OPERATING INCOME INCREASED 88% THIRD QUARTER 2016 GROSS MARGIN 51.2% COMPETITIVE CONVERSION REVENUE INCREASED 134% Deferred Revenue AS OF JULY 31, 2016 $7.6M MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today reported financial results for the third

MGC Diagnostics Corporation Announces Early Repayment of Debt; Settles Litigation with NeuroVirtual

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Announces Early Repayment of Debt; Settles Litigation with NeuroVirtual SAINT PAUL, MN ? June 14, 2016 ? MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today announced that it has

MGC Diagnostics FORM 10-Q FOR THE QUARTER ENDED APRIL 30, 2016 (Quarterly Report)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended April 30, 2016. OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to . Commission File Number 001-13543

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 1, 2016 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics Corporation Reports Fiscal 2016 Second Quarter Results

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Reports Fiscal 2016 Second Quarter Results SAINT PAUL, MN ? June 1, 2016 ? MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today reported financial results for the second quarter en

MGC Diagnostics Corporation CONFLICT MINERALS REPORT Reporting Year: 2015

Exhibit 1.01 MGC Diagnostics Corporation CONFLICT MINERALS REPORT Reporting Year: 2015 This is the Conflict Minerals Report (“Report”) of MGC Diagnostics Corporation (“MGCD” or the “Company”) for the 2015 calendar year in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exchange Act of 1934 (“the 1934 Act”). Please refer to Rule 13p-1, Form SD and the 1934 Act Release No. 34-67716 (A

MGC Diagnostics FORM SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form SD Specialized Disclosure Report MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota 001-13543 41-1579150 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.

MGCD / MGC Diagnostics Corp. / Radoff Bradley Louis - SC 13G Passive Investment

SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) MGC Diagnostics Corporation (Name of Issuer) Common Stock, $0.

MGC Diagnostics FORM 8-K DATED MARCH 16, 2016 (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 16, 2016 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics FORM S-8

As filed with the Securities and Exchange Commission on March 17, 2016 Registration No.

MGCD / MGC Diagnostics Corp. 10-Q - Quarterly Report - FORM 10-Q FOR THE QUARTER ENDED JANUARY 31, 2016

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended January 31, 2016. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to . Commission File Number 001-1354

Diagnostics Corporation Reports Fiscal 2016 First Quarter Results

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE Diagnostics Corporation Reports Fiscal 2016 First Quarter Results SAINT PAUL, MN (March 8, 2016) — MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today reported financial results for the first quarter ended J

MGC Diagnostics FORM 8-K DATED MARCH 8, 2016 (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 8, 2016 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGCD / MGC Diagnostics Corp. / PERCEPTIVE ADVISORS LLC - SC 13G/A Passive Investment

SC 13G/A 1 mgc13ga1.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Amendment No. 1) Under the Securities Exchange Act of 1934 MGC Diagnostics Corp (Name of Issuer) Common Stock (Title of Class of Securities) 552768103 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate

AMENDED AND RESTATED Bylaws of MGC DIAGNOSTICS Corporation ARTICLE I OFFICES AND CORPORATE SEAL

EX-3.2 2 mgc160437ex3-2.htm AMENDED AND RESTATED BYLAWS eXhibit 3.2 AMENDED AND RESTATED Bylaws of MGC DIAGNOSTICS Corporation ARTICLE I OFFICES AND CORPORATE SEAL The registered office of the corporation will be located at 350 Oak Grove Parkway, Saint Paul, Minnesota 55127 or in the most recent amendment thereof, or in a statement of the Board of Directors filed with the Secretary of State of the

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 2, 2016 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics DEFINITIVE PROXY STATEMENT

SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

MGC Diagnostics DEFINITIVE ADDITIONAL MATERIALS

SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

MGCD / MGC Diagnostics Corp. 10-K - Annual Report - FORM 10-K FOR THE FISCAL YEAR ENDED OCTOBER 31, 2015

10-K 1 mgcd16026210k.htm FORM 10-K FOR THE FISCAL YEAR ENDED OCTOBER 31, 2015 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended October 31, 2015. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 19

AMENDMENT NO. 2 CREDIT AGREEMENT

Exhibit 10.10.2 AMENDMENT NO. 2 to CREDIT AGREEMENT THIS AMENDMENT NO. 2 TO CREDIT AGREEMENT (“Amendment”) is made as of July 23, 2015, by and among MGC DIAGNOSTICS CORPORATION, a Minnesota corporation (“Holding Company”), and MEDICAL GRAPHICS CORPORATION, a Minnesota corporation (“Medical Graphics” and together with Holding Company, individually and collectively, and jointly and severally, the “B

MGC Diagnostics Corporation Policy on Director Election On Stock In Lieu Of Quarterly Retainer (as Amended, December 16, 2015)

EX-10.8 2 mgcd160262ex10-8.htm POLICY ON DIRECTOR ELECTION OF STOCK IN LIEU OF QUARTERLY RETAINER Exhibit 10.8 MGC Diagnostics Corporation Policy on Director Election On Stock In Lieu Of Quarterly Retainer (as Amended, December 16, 2015) MGC believes it is important for directors to own Company common stock and has adopted share ownership guidelines. Recognizing that it may be difficult for direct

Subsidiaries of MGC Diagnostics Corporation

Exhibit 21 Subsidiaries of MGC Diagnostics Corporation Name of Subsidiary Jurisdiction of Incorporation or Organization Medical Graphics Corporation Minnesota MGC Diagnostics Belgium S.P.R.L. Belgium Medisoft SA Belgium

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 5, 2016 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics Corporation Reports Fiscal Year 2015 Financial Results Fiscal year revenue increased 24.9% compared to prior year Net Income of $4.0 million vs. Net Loss of $(1.2 million) in 2014 EPS of $0.94 vs. $(0.28) in 2014

EX-99.1 2 mgc160052ex99-1.htm PRESS RELEASE DATED JANUARY 6, 2016 Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Reports Fiscal Year 2015 Financial Results Fiscal year revenue increased 24.9% compared to prior year Net Income of $4.0 million vs. Net Loss of $(1

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 6, 2016 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics Corporation Reports Fiscal 2015 Third Quarter Results

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Reports Fiscal 2015 Third Quarter Results Third Quarter Fiscal 2015 Highlights: ? Third quarter 2015 revenue increased by 40.1% to $9.2 million, compared to $6.6 million in the prior year period. Third quarter reve

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 10, 2015 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics FORM 8-K DATED MAY 28, 2015 (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported) : May 28, 2015 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results Second Quarter Fiscal 2015 Highlights: ? Second quarter 2015 revenue increased by 17.5% to $8.7 million, compared to $7.4 million in the prior year period. Second quarter

MGC Diagnostics FORM S-8

As filed with the Securities and Exchange Commission on June 1, 2015 Registration No.

MGC Diagnostics Corporation 2007 STOCK INCENTIVE PLAN Section 1 Purpose

Exhibit 4.1 MGC Diagnostics Corporation 2007 STOCK INCENTIVE PLAN Section 1 Purpose The purpose of the Plan is to enable MGC Diagnostics Corporation 1(the “Company”) and its Subsidiaries to attract and retain employees, directors and service providers of the Company by aligning financial interests of these individuals with the other shareholders of the Company. The Plan provides for the grant of I

MGC Diagnostics FORM SD

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form SD Specialized Disclosure Report MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota 001-13543 41-1579150 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics Corporation CONFLICT MINERALS REPORT Reporting Year: 2014

Exhibit 1.01 MGC Diagnostics Corporation CONFLICT MINERALS REPORT Reporting Year: 2014 This is the Conflict Minerals Report of MGC Diagnostics Corporation (“MGCD” or the “Company”) for the 2014 calendar year in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exchange Act of 1934 (“the 1934 Act”). Please refer to Rule 13p-1, Form SD and the 1934 Act Release No. 34-67716 (August 22, 2

MGC Diagnostics FORM 8-K DATED MARCH 18, 2015 (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 18, 2015 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results First Quarter Fiscal 2015 Highlights: · First quarter 2015 revenue increased by 41.9% to $8.9 million, compared to $6.3 million in the prior year period. First quarter reve

MGC Diagnostics FORM 8-K DATED MARCH 5, 2015 (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 5, 2015 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGCD / MGC Diagnostics Corp. / PERCEPTIVE ADVISORS LLC - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 MGC Diagnostics Corp (Name of Issuer) Common Stock (Title of Class of Securities) 552768103 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: x

MGCD / MGC Diagnostics Corp. DEF 14A - - DEFINIIVE PROXY STATEMENT

SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

MGCD / MGC Diagnostics Corp. DEFA14A - - DEFA14A

SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 7, 2015 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics Corporation Reports Fiscal 2014 Fourth Quarter and Full Year Results

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Reports Fiscal 2014 Fourth Quarter and Full Year Results Fourth Quarter Fiscal 2014 Highlights: • Fiscal Q4 revenue totaled $9.7 million, up 6.2% from $9.1 million in the prior year period. Fourth quarter 2014 reve

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 17, 2014 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION

Exhibit 99.3 UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION The Unaudited Pro Forma Condensed Consolidated Financial Statements have been primarily derived from the historical consolidated financial statements of MGC Diagnostics Corporation (“Company”) and MediSoft SA (“MediSoft”). The Unaudited Pro Forma Condensed Consolidated Statements of Income (Loss) of MGC Diagnostics Corpo

Independent auditor’s report

Exhibit 99.2 MediSoft SA and Subsidiaries CONSOLIDATED FINANCIAL STATEMENTS For the year ended December 31, 2013 INDEX PAGE Report of Independent Audit Firm 2 Consolidated Balance Sheet as of December 31, 2013 3 Consolidated Statement of Comprehensive Loss for the year ended December 31, 2013 4 Consolidated Statement of Changes in Stockholders’ Equity for the year ended December 31, 2013 5 Consoli

Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Amendment No.

MGC Diagnostics Corporation Reports 2014 Third Quarter Operating Results

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Reports 2014 Third Quarter Operating Results SAINT PAUL, MN (September 9, 2014) — MGC Diagnostics Corporation (NasdaqCM: MGCD), a global medical technology company, today reported financial results for the third qu

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 9, 2014 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Results of Operations and Financial Condition, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 1, 2014 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

STOCK PURCHASE AGREEMENT

Exhibit 10.1 STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT (including all schedules, exhibits and other agreements attached hereto or made a part hereof, and all amendments hereto, this “Agreement”) is made and entered into as of July 10, 2014, by and among MGC Diagnostics Belgium S.P.R.L., a private limited liability company incorporated under Belgium law and a subsidiary of MGC Diagnost

MGC DIAGNOSTICS CORPORATION WARRANT TO PURCHASE SHARES OF COMMON STOCK

Exhibit 4.1 MGC DIAGNOSTICS CORPORATION WARRANT TO PURCHASE SHARES OF COMMON STOCK Warrant No. August 1, 2014 THIS CERTIFIES THAT or its registered assigns (the “Holder”), is entitled to subscribe for and purchase from MGC Diagnostics Corporation, a Minnesota corporation (the “Company”), at any time on or before the Expiration Date (as defined below), 168,342 fully paid and nonassessable shares (t

MGC Diagnostics Corporation Completes Acquisition of MediSoft SA Strengthens MGCD as a global leader in cardiorespiratory diagnostic products

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Completes Acquisition of MediSoft SA Strengthens MGCD as a global leader in cardiorespiratory diagnostic products SAINT PAUL, MN (August 1, 2014) — MGC Diagnostics Corporation (NasdaqCM: MGCD), a leading global med

TERM NOTE

Exhibit 10.2 TERM NOTE $4,000,000 July 24, 2014 FOR VALUE RECEIVED, each of MGC DIAGNOSTICS CORPORATION, a Minnesota corporation, and MEDICAL GRAPHICS CORPORATION, a Minnesota corporation (individually and collectively, the “Borrower”), jointly and severally, promises to pay to the order of BMO HARRIS BANK N.A., a national banking association (the “Bank”), at its main office in Minneapolis, Minnes

CREDIT AGREEMENT

Exhibit 10.1 CREDIT AGREEMENT THIS CREDIT AGREEMENT, dated as of July 24, 2014, is by and among MGC DIAGNOSTICS CORPORATION, a Minnesota corporation (“Holding Company”) and MEDICAL GRAPHICS CORPORATION, a Minnesota corporation (“Medical Graphics”) (each of Holding Company and Medical Graphics are also referred to individually and collectively as the “Borrower” and each reference to the Borrower he

SECURITY AGREEMENT

Exhibit 10.4 SECURITY AGREEMENT THIS SECURITY AGREEMENT (this “Agreement”), dated as of July 24, 2014, is by and between MGC DIAGNOSTICS CORPORATION, a Minnesota corporation (the “Debtor”), and BMO HARRIS BANK N.A. (the “Secured Party”). RECITALS: A. The Debtor and Medical Graphics Corporation (individually and collectively, the “Borrower”) and the Secured Party are parties to that certain Credit

REVOLVING NOTE

Exhibit 10.3 REVOLVING NOTE $3,000,000 July 24, 2014 FOR VALUE RECEIVED, each of MGC DIAGNOSTICS CORPORATION, a Minnesota corporation, and MEDICAL GRAPHICS CORPORATION, a Minnesota corporation (individually and collectively, the “Borrower”), jointly and severally, promises to pay to the order of BMO HARRIS BANK N.A., a national banking association (the “Bank”), at its main office in Minneapolis, M

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported) : July 24, 2014 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics Corporation Completes Agreement to Acquire Medisoft SA Positions MGCD as a global leader in Cardiorespiratory diagnostic products

EX-99.1 2 mgc142590ex99-1.htm PRESS RELEASE DATED JULY 14, 2014 Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Completes Agreement to Acquire Medisoft SA Positions MGCD as a global leader in Cardiorespiratory diagnostic products SAINT PAUL, MN (July 14, 2014) —

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 10, 2014 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 30, 2014 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K DATED JUNE 12, 2014

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 12, 2014 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics Corporation Reports 2014 Second Quarter Operating Results

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Reports 2014 Second Quarter Operating Results SAINT PAUL, MN (June 12, 2014) — MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today reported financial results for the second quarte

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Other Events

8-K 1 mgc1420478k.htm FORM 8-K DATED MAY 29, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 29, 2014 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction

- FORM SD

SD 1 mgc141982sd.htm FORM SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form SD Specialized Disclosure Report MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota 001-13543 41-1579150 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 350 Oak Grove Parkway Saint Paul, Minnesota

MGC Diagnostics Corporation CONFLICT MINERALS REPORT Reporting Year: 2013

Exhibit 1.01 MGC Diagnostics Corporation CONFLICT MINERALS REPORT Reporting Year: 2013 This is the Conflict Minerals Report of MGC Diagnostics Corporation (“MGCD”) for the 2013 calendar year in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exchange Act of 1934 (“the 1934 Act”). Please refer to Rule 13p-1, Form SD and the 1934 Act Release No. 34-67716 (August 22, 2012) relating to

MGC Diagnostics Corporation Announces Executive Management Changes CEO Resigns to Accept New Opportunity; Company Promotes Three Executives Under Succession Plan

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Announces Executive Management Changes CEO Resigns to Accept New Opportunity; Company Promotes Three Executives Under Succession Plan SAINT PAUL, MN (May 20, 2014) — The Board of Directors of MGC Diagnostics Corpor

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - FORM 8-K DATED MAY 20, 2014

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 20, 2014 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders - FORM 8-K DATED MARCH 20, 2014

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 20, 2014 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics Announces its Intent to Acquire Medisoft SA| ACQUISITION would create A Global Leader in Cardio-Respiratory diagnostic products

Exhibit 99.1 MGC Diagnostics Corporation Through its subsidiary Medical Graphics Corporation 350 Oak Grove Parkway St. Paul, Minnesota USA, 55127-8599 MGC Diagnostics Announces its Intent to Acquire Medisoft SA| ACQUISITION would create A Global Leader in Cardio-Respiratory diagnostic products St. Paul, MN (March 20, 2014) - MGC Diagnostics Corp. (NASDAQ: MGCD) a leading global medical technologie

MGC Diagnostics FORM 10-Q FOR THE QUARTER ENDED JANUARY 31, 2014 (Quarterly Report)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended January 31, 2014. OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to . Commission File Number 001-1354

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K DATED MARCH 4, 2014

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 4, 2014 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics Corporation Reports 2014 First Quarter Operating Results

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Reports 2014 First Quarter Operating Results SAINT PAUL, MN (March 4, 2014) — MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today reported financial results for the first quarter

- DEFINITIVE ADDITIONAL MATERIALS

DEFA14A 1 mgc140362defa14a.htm DEFINITIVE ADDITIONAL MATERIALS SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the registrant ☒ Filed by a party other than the registrant ☐ Check the appropriate box: ☐ Confidential, for Use of the Commission Only (

- DEFINITIVE PROXY STATEMENT

SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

MGC Diagnostics FORM 10-K FOR THE FISCAL YEAR ENDED OCTOBER 31, 2013 (Annual Report)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended October 31, 2013. OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to . Commission File Number 001-13543 MGC DI

January 15, 2013

Exhibit 10.8 January 15, 2013 Wesley W. Winnekins Dear Wes: We are very pleased you are considering joining the MGC DIAGNOSTICS Team! The purpose of this letter is to extend an offer of employment. Carefully review the information enclosed and if you are in agreement signify your acceptance by signing the signature page and return it to me within three days. Position: Executive Vice President, Fin

MGC DIAGNOSTICS CORPORATION POLICY ON DIRECTOR ELECTION ON STOCK IN LIEU OF QUARTERLY RETAINER (ADOPTED MAY 29, 2013)

Exhibit 10.9 MGC DIAGNOSTICS CORPORATION POLICY ON DIRECTOR ELECTION ON STOCK IN LIEU OF QUARTERLY RETAINER (ADOPTED MAY 29, 2013) MGC believes it is important for directors to own Company common stock and has adopted share ownership guidelines. Recognizing that it may be difficult for directors to obtain stock in the open market from time to time, the Company has provided that a portion of non-em

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

8-K 1 mgc1352198k.htm FORM 8-K DATED DECEMBER 18, 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 18, 2013 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jur

MGC Diagnostics Corporation Reports 2013 Fourth Quarter and Year End Operating Results

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Reports 2013 Fourth Quarter and Year End Operating Results SAINT PAUL, MN (December 19, 2013) — MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today reported financial results for

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 19, 2013 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGCD / MGC Diagnostics Corp. / PESSIN NORMAN H - NORMAN H. PESSIN SC 13D A NO 4 10-29-2013 (MGC DIAGNOSTICS CORPORATION) Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* MGC Diagnostics Corporation (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 552768103 Cusip Number Norman H. Pessin 366 Madison Avenue, 14th Floor New York, NY 10017 212-661-2670 (Name, Address and Telephone Number of Person

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 29, 2013 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics Corporation Reports 2013 Third Quarter Operating Results

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Reports 2013 Third Quarter Operating Results SAINT PAUL, MN (August 29, 2013) — MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today reported financial results for the third quarte

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K DATED MAY 30, 2013

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 30, 2013 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics Corporation Reports 2013 Second Quarter Operating Results

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Reports 2013 Second Quarter Operating Results SAINT PAUL, MN (May 30, 2013) — MGC Diagnostics Corporation (NASDAQ: MGCD) (formerly Angeion Corporation), a global medical technology company, today reported financial

ULGX / Urologix, Inc. / BlueLine Partners, L.L.C. - SCHEDULE 13D/A Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13D Under the Securities Exchange Act of 1934 (Amendment No. 3) MGC Diagnostics Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 45326F207 (CUSIP Number) Timothy P. Bacci BlueLine Partners, LLC c/o BlueLine Management Company 319 Diablo Road, Suite 200 Danville, California 94526 (Name, Address and Telephone

MGC Diagnostics Corporation Announces Special Cash Dividend and Extension of Stock Repurchase Program

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Announces Special Cash Dividend and Extension of Stock Repurchase Program SAINT PAUL, MN (March 28, 2013) — MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology leader, announced that its Board o

Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders - FORM 8-K DATED MARCH 27, 2013

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 27, 2013 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K DATED MARCH 5, 2013

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 5, 2013 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics Corporation Reports 2013 First Fiscal Quarter Operating Results

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Reports 2013 First Fiscal Quarter Operating Results SAINT PAUL, MN (March 5, 2013) — MGC Diagnostics Corporation (NASDAQ: MGCD) (formerly Angeion Corporation), a global medical technology company, today reported fi

- DEFINITIVE PROXY STATEMENT

SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

- DEFINITIVE ADDITIONAL MATERIALS

SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

MGC Diagnostics Corporation Appoints Wesley W. Winnekins as Executive Vice President, Finance and Corporate Development; Winnekins will also serve as Chief Financial Officer

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Appoints Wesley W. Winnekins as Executive Vice President, Finance and Corporate Development; Winnekins will also serve as Chief Financial Officer SAINT PAUL, MN (February 4, 2013) — MGC Diagnostics Corporation (NAS

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - FORM 8-K DATED FEBRUARY 1, 2013

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 1, 2013 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K DATED DECEMBER 18, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 18, 2012 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K DATED DECEMBER 19, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 19, 2012 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics Corporation Reports Fourth Quarter and Fiscal Year 2012 Operating Results

Exhibit 99.1 MGC Diagnostics Corporation 350 Oak Grove Parkway Saint Paul, MN 55127 Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Reports Fourth Quarter and Fiscal Year 2012 Operating Results SAINT PAUL, MN (December 19, 2012) — MGC Diagnostics Corporation (NASDAQ: MGCD) (formerly Angeion Corporation), a global medical technology company, tod

MGC Diagnostics Corporation Completes Sale of New Leaf Business Assets to Life Time – The Healthy Way of Life Company

Exhibit 99.1 MCG Diagnostics Corporation 350 Oak Grove Parkway St. Paul, MN 55127 USA Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Completes Sale of New Leaf Business Assets to Life Time – The Healthy Way of Life Company SAINT PAUL, MN (August 30, 2012) — MGC Diagnostics Corporation (NASDAQ: MGCD), (formerly Angeion Corporation (NASDAQ:ANGN)

Financial Statements and Exhibits, Results of Operations and Financial Condition, Completion of Acquisition or Disposition of Assets - FORM 8-K DATED AUGUST 28, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 28, 2012 MGC Diagnostics Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

MGC Diagnostics Corporation Reports Third Quarter Fiscal Year 2012 Operating Results

Exhibit 99.2 MCG Diagnostics Corporation 350 Oak Grove Parkway St. Paul, MN 55127 USA Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE MGC Diagnostics Corporation Reports Third Quarter Fiscal Year 2012 Operating Results SAINT PAUL, MN (August 30, 2012) — MGC Diagnostics Corporation (NASDAQ: MGCD) (formerly Angeion Corporation (NASDAQ:ANGN)), a global medical technology com

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits - FORM 8-K DATED AUGUST 21, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): August 21, 2012 MGC Diagnostics Corporation (Exact name of Registrant as Specified in its Charter) Minnesota (State Or Other Jurisdiction Of Incorporation) 001-13543 41-1579150 (Commi

ARTICLES OF AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION OF ANGEION CORPORATION

Exhibit 3.1 ARTICLES OF AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION OF ANGEION CORPORATION The undersigned, an officer of Angeion Corporation, a Minnesota corporation, in order to amend the Amended and Restated Articles of Incorporation, effective as of August 21, 2012, hereby states as follows: The following Amendment to the Amended and Restated Articles of Incorporation of Angeio

Submission of Matters to a Vote of Security Holders - FORM 8-K DATED MAY 30, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 30, 2012 Angeion Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

- FORM S-8

S-8 1 angeion122341s8.htm FORM S-8 As filed with the Securities and Exchange Commission on June 4, 2012. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ANGEION CORPORATION (Exact name of registrant as specified in its charter) Minnesota 41-1579150 (State or other jurisdiction of (I.R.S.

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K DATED MAY 31, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 31, 2012 Angeion Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

Angeion Corporation Reports Second Quarter Fiscal Year 2012 Operating Results

Exhibit 99.1 Angeion Corporation 350 Oak Grove Parkway St. Paul, MN 55127 USA Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE Angeion Corporation Reports Second Quarter Fiscal Year 2012 Operating Results SAINT PAUL, MN (May 31, 2012) — Angeion Corporation (NASDAQ: ANGN) today reported financial results for the second quarter of fiscal year 2012 ended April 30, 2012. Secon

Regulation FD Disclosure - FORM 8-K DATED MAY 30, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 30, 2012 Angeion Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

- DEFINITIVE ADDITIONAL MATERIALS

SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

- DEFINITIVE PROXY STATEMENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

Wendy D. Lynch, Ph.D., Joins Angeion’s Board of Directors

Exhibit 99.1 Angeion Corporation 350 Oak Grove Parkway St. Paul, MN 55127 USA Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE Wendy D. Lynch, Ph.D., Joins Angeion’s Board of Directors SAINT PAUL, MN (March 5, 2012) — Angeion Corporation (NASDAQ: ANGN) today announced that Wendy D. Lynch, Ph.D., has been appointed to the Company’s Board of Directors, effective March 1, 201

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - FORM 8-K DATED FEBRUARY 28, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 28, 2012 Angeion Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.

Angeion Corporation Reports First Quarter Fiscal Year 2012 Operating Results

Exhibit 99.1 Angeion Corporation 350 Oak Grove Parkway St. Paul, MN 55127 USA Telephone: (651) 484-4874 Facsimile: (651) 484-4826 FOR IMMEDIATE RELEASE Angeion Corporation Reports First Quarter Fiscal Year 2012 Operating Results SAINT PAUL, MN (February 28, 2012) — Angeion Corporation (NASDAQ: ANGN) today reported financial results for its first quarter fiscal 2012 ended January 31, 2012. First Qu

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K DATED FEBRUARY 28, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 28, 2012 Angeion Corporation (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 001-13543 41-1579150 (Commission File Number) (IRS Employer Identification No.